VIRUS ENCODED MIMITOPE PROCESSING IN AUTOIMMUNE DIABETES

自身免疫性糖尿病中病毒编码的拟表位加工

基本信息

  • 批准号:
    2673021
  • 负责人:
  • 金额:
    $ 8.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-06-01 至 2000-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (adapted from applicant's abstract): In both humans and the NOD mouse model, insulin dependent diabetes (IDDM) results from autoimmune destruction of pancreatic beta cells by T lymphocytes. Thus far, it is not known which specific subpopulations of antigen presenting cells (APCs - B lymphocytes, macrophages or dendritic cells) contribute to the development and activation of diabetogenic T lymphocytes. Preliminary data show that B lymphocytes play an essential role, since disease incidence is completely inhibited in a stock of NOD mice made B lymphocyte deficient by congenic transfer of a functionally disrupted Ig-mu allele (NOD.Ig-mu null). Preliminary data also show that B lymphocytes are the only APC population that can immunologically process glutamic acid decarboxylase (GAD), which may be the earliest beta cell antigen targeted by autoreactive T lymphocytes in NOD mice. In addition, an epitope in GAD that is reported to be preferentially presented by APC to autoreactive T lymphocytes in both NOD mice and human IDDM patients is highly homologous with a segment of the Coxsackie virus P2-C protein. Thus Coxsackie virus infection may provide a cross-reactive antigenic trigger for the activation of diabetogenic GAD autoreactive T lymphocytes in genetically susceptible individuals. Furthermore, normally quiescent, diabetogenic T lymphocytes may still develop in B lymphocyte deficient NOD.Ig-mu null mice if other subpopulations of APC have the capacity to generate mimics of beta cell autoantigens from infectious agents such as Coxsackie virus. To test this hypothesis, the investigators will pursue two major aims. The first is to determine whether B lymphocytes are required for the development as well the functional activation of T lymphocytes capable of responding to various GAD-derived peptides in NOD mice. The second is to determine if IDDM resistance in NOD.Ig-mu null mice can be abrogated by priming with GAD derived peptides or a Coxsackie viral infection that may bypass the normal requirement for B lymphocytes to generate antigenic epitopes from native GAD. These studies will provide insights to the basic mechanisms by which beta cell antigens are presented to autoreactive T lymphocytes in IDDM, and how these processes may be influenced by a Coxsackie viral infection.
描述(改编自申请人摘要):在人类和NOD中

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David V Serreze其他文献

David V Serreze的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David V Serreze', 18)}}的其他基金

B-lymphocyte Targeting Therapies for Autoimmune Diabetes
B 淋巴细胞靶向治疗自身免疫性糖尿病
  • 批准号:
    10440062
  • 财政年份:
    2013
  • 资助金额:
    $ 8.11万
  • 项目类别:
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
B 淋巴细胞靶向治疗自身免疫性糖尿病
  • 批准号:
    9925207
  • 财政年份:
    2013
  • 资助金额:
    $ 8.11万
  • 项目类别:
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
B 淋巴细胞靶向治疗自身免疫性糖尿病
  • 批准号:
    9043052
  • 财政年份:
    2013
  • 资助金额:
    $ 8.11万
  • 项目类别:
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
B 淋巴细胞靶向治疗自身免疫性糖尿病
  • 批准号:
    8641351
  • 财政年份:
    2013
  • 资助金额:
    $ 8.11万
  • 项目类别:
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
B 淋巴细胞靶向治疗自身免疫性糖尿病
  • 批准号:
    8501988
  • 财政年份:
    2013
  • 资助金额:
    $ 8.11万
  • 项目类别:
B-lymphocyte Targeting Therapies for Autoimmune Diabetes
B 淋巴细胞靶向治疗自身免疫性糖尿病
  • 批准号:
    10609074
  • 财政年份:
    2013
  • 资助金额:
    $ 8.11万
  • 项目类别:
Type 1 Diabetes Mouse Resource (T1DR)
1 型糖尿病小鼠资源 (T1DR)
  • 批准号:
    8435054
  • 财政年份:
    2012
  • 资助金额:
    $ 8.11万
  • 项目类别:
Becton Dickinson LSR-II Analytical Cytometer (BD-LSR-II)
Becton Dickinson LSR-II 分析细胞仪 (BD-LSR-II)
  • 批准号:
    7388576
  • 财政年份:
    2008
  • 资助金额:
    $ 8.11万
  • 项目类别:
VIRUS ENCODED MIMITOPE PROCESSING IN AUTOIMMUNE DIABETES
自身免疫性糖尿病中病毒编码的拟表位加工
  • 批准号:
    2371913
  • 财政年份:
    1997
  • 资助金额:
    $ 8.11万
  • 项目类别:
VIRUS ENCODED MIMITOPE PROCESSING IN AUTOIMMUNE DIABETES
自身免疫性糖尿病中病毒编码的拟表位加工
  • 批准号:
    2887472
  • 财政年份:
    1997
  • 资助金额:
    $ 8.11万
  • 项目类别:

相似海外基金

Effect of tofacitinib on skin initiated autoimmunity in the NOD mouse
托法替布对 NOD 小鼠皮肤引发的自身免疫的影响
  • 批准号:
    324045
  • 财政年份:
    2015
  • 资助金额:
    $ 8.11万
  • 项目类别:
    Studentship Programs
The mechanism of axonal degeneration caused by demyelination in B7-2 KO NOD mouse
B7-2 KO NOD小鼠脱髓鞘导致轴突变性的机制
  • 批准号:
    26461292
  • 财政年份:
    2014
  • 资助金额:
    $ 8.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of slowly progressive type 1 diabetes animal models using the CD28 knock-out NOD mouse
使用 CD28 敲除 NOD 小鼠开发缓慢进展的 1 型糖尿病动物模型
  • 批准号:
    24591319
  • 财政年份:
    2012
  • 资助金额:
    $ 8.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effect of diet & commensal bacteria on diabetes outcome in NOD mouse
饮食的影响
  • 批准号:
    7941018
  • 财政年份:
    2009
  • 资助金额:
    $ 8.11万
  • 项目类别:
Effect of diet & commensal bacteria on diabetes outcome in NOD mouse
饮食的影响
  • 批准号:
    7824956
  • 财政年份:
    2009
  • 资助金额:
    $ 8.11万
  • 项目类别:
Effect of Ag-specific CD8+ T cell deletion on diabetogenesis in the NOD mouse
Ag 特异性 CD8 T 细胞缺失对 NOD 小鼠糖尿病发生的影响
  • 批准号:
    7813865
  • 财政年份:
    2008
  • 资助金额:
    $ 8.11万
  • 项目类别:
Effect of Ag-specific CD8+ T cell deletion on diabetogenesis in the NOD mouse
Ag 特异性 CD8 T 细胞缺失对 NOD 小鼠糖尿病发生的影响
  • 批准号:
    8066587
  • 财政年份:
    2008
  • 资助金额:
    $ 8.11万
  • 项目类别:
Effect of Ag-specific CD8+ T cell deletion on diabetogenesis in the NOD mouse
Ag 特异性 CD8 T 细胞缺失对 NOD 小鼠糖尿病发生的影响
  • 批准号:
    7471656
  • 财政年份:
    2008
  • 资助金额:
    $ 8.11万
  • 项目类别:
Effect of Ag-specific CD8+ T cell deletion on diabetogenesis in the NOD mouse
Ag 特异性 CD8 T 细胞缺失对 NOD 小鼠糖尿病发生的影响
  • 批准号:
    7809134
  • 财政年份:
    2008
  • 资助金额:
    $ 8.11万
  • 项目类别:
Effect of Ag-specific CD8+ T cell deletion on diabetogenesis in the NOD mouse
Ag 特异性 CD8 T 细胞缺失对 NOD 小鼠糖尿病发生的影响
  • 批准号:
    7585202
  • 财政年份:
    2008
  • 资助金额:
    $ 8.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了